Wedbush Remains a Hold on Cross Country Healthcare (CCRN)

In a report released today, from Wedbush maintained a Hold rating on Cross Country Healthcare, with a price target of $11.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

In addition to Wedbush, Cross Country Healthcare also received a Hold from TipRanks – OpenAI’s OpenAI Medical – Care Facilities in a report issued today. However, on the same day, Benchmark Co. upgraded Cross Country Healthcare (NASDAQ: CCRN) to a Buy.

Based on Cross Country Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $82.93 million. In comparison, last year the company earned a revenue of $309.94 million and had a GAAP net loss of $3.75 million

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year. Most recently, in December 2025, Larry W. Cash, a Director at CCRN bought 5,000.00 shares for a total of $40,788.00.